Evaluation of a 3D convolutional neural network algorithm for organ segmentation and quantification of tissue metabolism in FDG-PET/CT

1439 null Objectives: null null 18F-FDG PET is routinely used to assess glucose metabolism in tumours, providing information on the likelihood of malignancy and on response evaluation during treatment. FDG uptake in tissues not directly involved in disease can provide additional information on response and side-effects, but its clinical utility is largely unassessed due to the impracticality of manually segmenting organs on PET/CT. As a step...